Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.
Pharmacol Res
; 159: 104938, 2020 09.
Article
em En
| MEDLINE
| ID: mdl-32504831
Palavras-chave
Angiogenesis; Cancer; FENTANYL: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide; Immunosuppression; METHYLNALTREXONE: (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one; MORPHINE: (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol; Metastasis; NALOXONE: (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one; NALTREXONE: (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one; Opioid receptors; Opioids; TAPENTADOL: 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol; TRAMADOL: (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Receptores Opioides
/
Dor do Câncer
/
Analgésicos Opioides
/
Antagonistas de Entorpecentes
/
Neoplasias
/
Antineoplásicos
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Pharmacol Res
Assunto da revista:
FARMACOLOGIA
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Itália